10. ReCor Medical: Paradise renal denervation system
ReCor Medical won FDA breakthrough device designation for its Paradise ultrasound renal denervation system in December. The system is an investigational device that is designed to treat hypertensive patients who may not be sufficiently responsive to or are intolerant of anti-hypertensive medical therapy.
The technology is catheter-based and uses ultrasound energy to interrupt the renal sympathetic nervous system for better blood pressure control.
ReCor’s Paradise requires a minimally invasive procedure to treat overactive nerves that lead to the kidneys. Doctors make a small incision in the groin to insert a small, flexible catheter and place it in the artery supplying the kidney. The device delivers ultrasound energy to the tissue surrounding the artery for several seconds. That energy creates heat to decrease the over-activity of the nerves leading to the kidney, allowing both kidneys to be treated. Once the treatment is completed, the device is removed.